Drug Trial Radar · NCT04609904
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)
Last checked: Nov 19, 2026Latest source record: Jul 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,187
Actual
Start
Mar 1, 2021
Primary completion
Mar 20, 2025
Study completion Mar 20, 2025
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Oct 30, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with standard of care.
Conditions
- Asthma
Interventions
BGF MDI 320/28.8/9.6 μgDrug
Budesonide, glycopyrronium, and formoterol fumarate metered dose inhaler
BGF MDI 320/14.4/9.6 μgDrug
Budesonide, glycopyrronium, and formoterol fumarate metered dose inhaler
BFF MDI 320/9.6 μgDrug
Budesonide and formoterol fumarate metered dose inhaler
BFF pMDI 320/9 μgDrug
Budesonide/formoterol fumarate pressurized metered dose inhaler
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in FEV1 AUC0-3 (L) at Week 24Time frame: Week 24
- Pooled (LOGOS/KALOS): Rate of Severe Asthma ExacerbationsTime frame: Up to 52 Weeks
Locations
317 sites in 16 countries. Site status is shown where the registry gives one.
Research Site
Chandler, Arizona
Research Site
Tempe, Arizona
Research Site
Tucson, Arizona
Research Site
Hot Springs, Arkansas
Research Site
Bakersfield, California
Research Site
Carlsbad, California
Research Site
Huntington Beach, California
Research Site
Lancaster, California
Research Site
Long Beach, California
Research Site
Mission Viejo, California
Research Site
North Hollywood, California
Research Site
Northridge, California
Research Site
Rancho Cucamonga, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Jose, California
Research Site
Ventura, California
Research Site
Walnut Creek, California
Research Site
Colorado Springs, Colorado
Research Site
Colorado Springs, Colorado
Research Site
Wheat Ridge, Colorado
Research Site
Newark, Delaware
Research Site
Boca Raton, Florida
Research Site
Clearwater, Florida
Research Site
Clearwater, Florida
Research Site
Cutler Bay, Florida
Research Site
DeBary, Florida
Research Site
Hialeah, Florida
Research Site
Lakeland, Florida
Research Site
Miami, Florida
Research Site
Tampa, Florida
Research Site
Acworth, Georgia
Research Site
Atlanta, Georgia
Research Site
Atlanta, Georgia
Research Site
Snellville, Georgia
Research Site
Boise, Idaho
Research Site
Chicago, Illinois
Research Site
Normal, Illinois
Research Site
Peoria, Illinois
Research Site
Evansville, Indiana
Showing 40 of 317 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.